u/vikram_ferreira

Same. A quiet fortnight after stopping tells you very little; the interesting part starts later.

Delayed gastric emptying is most pronounced early and attenuates with continued dosing, which is why the reflux usually fades at a stable dose.

Has appetite changed yet, independent of the scale?

Edited a comment framing regain as a moral failure.

Agreed — and the exposure lag means the first fortnight tells you almost nothing.

The habits are what carried it for a while. When they slipped, everything else followed, in that order.

Research-use-only material is not approved for human use, so anything in this thread about how a compounded or research vial "should" behave is a chemistry discussion, not a dosing one.

if the price is impossible, the material is the thing being economised on

The appetite thing was the surprise. I expected to feel full. What I got was simply not thinking about food between meals.

week 16 plateau is the most predictable thing in this entire board

With a week-long half-life, exposure declines over several weeks after the last dose rather than stopping with it. The lag is why the first fortnight is uninformative.

stopping is a plan, not an event

a cloned storefront copies the design, never the documentation

Cloned storefronts copy assets, layout and testimonial text. What they cannot easily copy is a batch-specific document that ties to a lot you can then have tested independently.

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

Correction: that study measured regain after discontinuation, not loss of effect during treatment. Very different findings.

With a week-long half-life, exposure declines over several weeks after the last dose rather than stopping with it. The lag is why the first fortnight is uninformative.

That is a report count, not a test count, and it changes how thin the evidence base actually is.

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

How long was the stall before you decided it was a stall?

have the conversation with a clinician before, not after

a domain registered last month with a decade of testimonials is the whole tell

Domain age, registrar and certificate issuance date are all public and take about a minute to check. A site claiming years of history on a months-old domain is the cheapest signal available.

Do muscle cramps track the day after the shot, or is it there all week?

Correcting myself from earlier in the thread: I said week 2 and it was week 6. Same shape, wrong number.

Interval stretching lowers the trough concentration while keeping the dose; dose reduction lowers the level while keeping the rhythm. They are different interventions with different subjective profiles.

Careful. A four-week stall is inside normal variation and treating it as failure is how people escalate for no reason.

the appetite signal and the scale move on different clocks

Do you have anything in writing from before the payment?

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

a domain registered last month with a decade of testimonials is the whole tell

if the price is impossible, the material is the thing being economised on

Stopped for cost reasons. Appetite came back at about week 18, well before the scale moved, exactly as this board said it would.

Stretching the interval or reducing the dose?

Week 83: 20kg down, constipation basically gone since about week 4, and the honest headline is that nothing dramatic happened. It was boring and it worked.

Yes. Week 7 is when almost everybody writes the "is it still working" post, and almost everybody is fine.

Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.

Leaving this up.

Right, and the timescale is the bit that keeps getting lost. Judge a step at a month, not at a weekend.

Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.

Research-use-only material is not approved for human use, so anything in this thread about how a compounded or research vial "should" behave is a chemistry discussion, not a dosing one.

STEP-1 averaged just under 15% at 68 weeks, so a 10% year is not a failure